Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nutritional Supplementation for Esophageal Cancer Patients Undergoing Trimodality Therapy

NCT04029857 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT04029857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04029857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nutritional Supplementation for Esophageal Cancer Patients Undergoing Trimodality Therapy
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 3
Overall status
Withdrawn
Start date
March 14, 2019
Completion date
January 31, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage iii esophageal adenocarcinoma ajcc v8, clinical stage iii esophageal squamous cell carcinoma ajcc v8, pathologic stage iii esophageal adenocarcinoma ajcc v8, pathologic stage iii esophageal squamous cell carcinoma ajcc v8, pathologic stage iiia esophageal adenocarcinoma ajcc v8, pathologic stage iiia esophageal squamous cell carcinoma ajcc v8, pathologic stage iiib esophageal adenocarcinoma ajcc v8, pathologic stage iiib esophageal squamous cell carcinoma ajcc v8, postneoadjuvant therapy stage iii esophageal adenocarcinoma ajcc v8, postneoadjuvant therapy stage iii esophageal squamous cell carcinoma ajcc v8, postneoadjuvant therapy stage iiia esophageal adenocarcinoma ajcc v8, postneoadjuvant therapy stage iiia esophageal squamous cell carcinoma ajcc v8, postneoadjuvant therapy stage iiib esophageal adenocarcinoma ajcc v8, postneoadjuvant therapy stage iiib esophageal squamous cell carcinoma ajcc v8, resectable mass